Transgenic plant expressing maltogenic alpha-amylase
CA 2348367 C · Owner: Kjaerulff, Soren · Inventors: Kjaerulff, Soren; Nielsen, Jack Bech
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A transgenic plant cell expressing a maltogenic amylase (such as Novamyl®) or a beta-amylase; a transgenic plant regenerated from said cell; seeds generated from such plant where said seeds comprise a maltogenic amylase or a beta-amylase and the use of said-seeds optionally in ground form, for catalyzing an industrial process such as e.g. , in baking. The maltogenic amylase providing an anti staling effect in bread produced from the seeds in question.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 1999 and granted May 8, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 12, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.